 |
 |
Access to Medicines
PIJIP provides research assistance and representation to local and international organizations, developing country governments, state and local governments, and others seeking to facilitate access to affordable medications in the U.S. and abroad. Some of PIJIP's recent activities have included submitting briefs in federal appellate courts and testifying before legislatures supporting state efforts to regulate medicine prices, analyzing the impact of free trade agreements on access to medicines in developing countries, and providing legal research to AIDS Activists in South Africa investigating competition claims against multinational pharmaceutical companies.
Intellectual Property, US Trade Policy and Health
PIJIP research and events explore the impact of intellectual property and trade policy on public health in the U.S. and abroad. Some of our research pages focus on specific trade disputes or bilateral Free Trade Agreements, while others address more general issues of American trade and innovation policy.
- COMPULSORY LICENSING DISPUTE IN THAILAND
- CANADA TO EXPORT GENERIC ANTIRETROVIRALS PRODUCED UNDER COMPULSORY LICENSE TO RWANDA
- KOREA-US FREE TRADE AGREEMENT
- PERU, PANAMA AND COLUMBIA FTAS
- COMPETITION (ANTITRUST) LAW AND AND ACCESS TO MEDICINES
- INDIAN COURT CASE ON NEW PATENTS ACT
- SECOND GENERATION ANTIRETROVIRALS
- BRAZIL (time line on compulsory licensing)
- US GOVERNMENT DOCUMENTS ON INTELLECTUAL PROPERTY, TRADE AND HEALTHCARE
- BALANCING INNOVATION AND ACCESS TO MEDICINES
State Policy on Prescription Drug Prices
PIJIP provides legal and policy advice and supports research and public education on the legality of state and local government measures to temper the effects of extreme monopoly pricing of patented medicines.
Partners
PIJIP works with other civil society groups concerned with access to medicine and innovation at both the international and domestic levels. Some of the groups were work with are linked below.
